Hiroshi Ureshino^1,2, Tatsuro Watanabe¹, Kazuharu Kamachi^1,2, Yuki Kurahashi¹, Yuki Kurahashi¹, Kaoru Tohyama³, Seiji Okada⁴, Hironori Harada⁵, Toshikazu Ushijima⁶, Shinya Kimura^1,2 (1.Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan, 2.Div. Hematology, Respiratory Medicine and Oncology, Saga, Japan, 3.Department of Laboratory Medicine, Kawasaki Medical School, Kawasaki, Japan, 4.Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto, Japan, 5.Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan, 6.Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan)

Yusuke Kizawa¹, Shiro Koh^1,2, Soichiro Nakako¹, Mitsuharu Hashimura¹, Hiroyoshi Ichihara¹, Shoji Ine¹, Atsuko Mugitani¹ (1.Hematol., Fuchu Hospital., Tokyo, Japan, 2.Hematol., Osaka City Univ., Tokyo, Japan)

Naoki Mori^1,2, Mari Ohwashi¹, Kentaro Yoshinaga¹, Masayuki Shiseki¹, Hiroshi Sakura², Junji Tanaka¹ (1.Hematol., Tokyo Women's Med. Univ., Tokyo, Japan, 2.Intern. Med., Tokyo Women's Med. Univ., East, Tokyo, Japan)

Yuhei Shibata¹, Yuto Kaneda², Yoshikazu Ikoma¹, Kimihiro Yamaguchi², Takuro Matsumoto², Nobuhiko Nakamura², Hiroshi Nakamura², Soranobu Ninomiya², Junichi Kitagawa², Nobuhiro Kanemura², Naoe Goto¹, Yasuhito Nanya⁴, Seishi Ogawa⁴, Senji Kasahara¹, Hisashi Tsurumi³, Takeshi Takahashi¹ (1.Dept. Hematol., Gifu Muni. Hosp., Gifu, Japan, 2.Hematol., Gifu Univ., Gifu, Japan, 3.Dept. Hematol., Matsunami Gene. Hosp., Gifu, Japan, 4.Dept. Pathol. and Tumor Biol., Kyoto Univ., Kyoto, Japan)

Kazuki Tanimura, Chika Nitani, Yuki Okuhiro, Kota Hira, Kai Yamasaki, Keiko Okada, Hiroyuki Fujisaki, Junichi Hara (Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan)

Aiko Sawazaki¹, Go Aoki¹, Kouhei Yamashita² (1.Dept. Int. Med., Fukui-ken Saiseikai Hospital, Fukui, Japan, 2.Dept. Hematol. Oncol., Kyoto Univ., Kyoto, Japan)

Kentaro Yamaguchi¹, Masatoshi Sakurai¹, Rie Yamazaki^1,2, Yuya Koda¹, Ryohei Abe¹, Kenji Yokoyama³, Shinichiro Okamoto¹, Takehiko Mori¹ (1.Division of Hematology, Department of Medicine, Keio University, Tokyo, 2.Center for Transfusion Medicine and Cell Therapy, Keio University, Tokyo, 3.Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo)

Noriko Kubota¹, Kazuo Sakashita², Nao Yoshida³, Koshi Akahane⁴, Takeshi Mori⁵, Nobuhisa Takahashi⁶, Atsushi Kikuta⁶, Jun Kobayashi¹, Takashi Kurata², Eiko Hidaka¹ (1.Department of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan, 2.Department of Hematology/Oncology, Nagano Children's Hospital, Azumino, Japan, 3.Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 4.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 5.Department of Pediatrics, Kobe University, Kobe, Japan, 6.Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan)